WHO WE ARE
As a family-held company, we are cognisant of how work shapes who we are and who we want to become. Our culture is enriched with a genuine ambition to make a mark, and together we strive to become individuals of remarkable value.
WHO WE ARE Aspiration & Values Leadership Our defining moments Sustainability Code of conduct Global presence
OUR FOCUS
We are a highly specialised company focused on carbohydrate chemistry and a global leader in the development of innovative treatments for patients suffering from iron deficiency and iron deficiency anaemia – a condition which more than 1 billion people live with, making it one of the largest global health challenges of our time.
OUR FOCUS Pharmaceuticals Carbohydrates Animal Health
PROGRAMMES
Discover our current research programme which highlight our commitment to groundbreaking studies and treatments, based on our expertise in iron metabolism.
PROGRAMMES Clinical Trials Petadeferitrin
CAREER
We are a fully integrated pharmaceutical company with many exciting opportunities ahead of us. Do you want to join us?
CAREER Job openings Life at Pharmacosmos
NEWS & MEDIA
We always strive to achieve new results and collaborations that can improve the quality of lives. Stay informed with our latest news and press releases.
NEWS & MEDIA News & Press Events Media
CONTACT US
We welcome all questions or inquiries. Get started by filling out a form or read about the way we are partnering.
CONTACT US Partnering with us Privacy policy

Home Who we are Leadership Lars L. Thomsen

Lars L. Thomsen

From Danish Healthcare Roots to Pharma Industry Leadership

Profile

Executive Vice President, CMO

MD, PhD, DMSc

Extensive experience from Danish healthcare to pharma industry

Lars Lykke Thomsen joined Pharmacosmos on 1 March 2009 as Chief Medical Officer.

Lars has gained extensive clinical experience through his employment in the Danish Healthcare system from 1992 to 2000. Following this he joined the pharmaceutical industry, first with H. Lundbeck A/S and since 2009 with Pharmacosmos.

His focus areas in Pharmacosmos are clinical and non-clinical research. Lars has additional experience in medical affairs, business development, pharmacovigilance and regulatory affairs at international level.

Lars was appointed Adjunct Professor at Aalborg University in 2016.

Go to Leadership